Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for shares of Phibro Animal Health in a note issued to investors on Wednesday, April 9th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.51 per share for the quarter, up from their prior estimate of $0.50. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2025 earnings at $0.52 EPS, FY2025 earnings at $1.92 EPS, Q2 2026 earnings at $0.57 EPS, FY2026 earnings at $1.97 EPS, Q2 2027 earnings at $0.57 EPS and FY2027 earnings at $2.23 EPS.
Several other equities analysts have also weighed in on PAHC. Barclays lifted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Finally, StockNews.com cut shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday, March 25th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $21.00.
View Our Latest Report on PAHC
Phibro Animal Health Stock Performance
Shares of PAHC traded down $1.13 during trading hours on Thursday, reaching $16.78. 93,127 shares of the company traded hands, compared to its average volume of 189,297. The business has a fifty day moving average price of $22.11 and a 200-day moving average price of $22.43. The stock has a market capitalization of $679.76 million, a P/E ratio of 34.96, a P/E/G ratio of 0.45 and a beta of 0.63. Phibro Animal Health has a 12-month low of $12.30 and a 12-month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.
Phibro Animal Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.
Institutional Trading of Phibro Animal Health
Hedge funds have recently added to or reduced their stakes in the business. Sterling Capital Management LLC boosted its position in Phibro Animal Health by 2.4% in the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock valued at $394,000 after buying an additional 448 shares during the last quarter. Rhumbline Advisers grew its holdings in Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock worth $1,608,000 after acquiring an additional 484 shares during the period. Los Angeles Capital Management LLC increased its holdings in shares of Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock valued at $505,000 after buying an additional 503 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after acquiring an additional 729 shares during the period. Finally, New York State Teachers Retirement System grew its holdings in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after buying an additional 775 shares in the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories

Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.